Pancreatic cancer: The role of pancreatic stellate cells in tumor progression

Pancreatology

Volumn 10, Issue 6, 2011, Pages 673-681

  Dunér, Siri ^a   Lopatko Lindman, Jacob ^a   Ansari, Daniel ^a   Gundewar, Chinmay ^a   Andersson, Roland ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Desmoplasia; Pancreatic cancer, treatment; Signal transduction; Stellate cells

Indexed keywords

ADRENOMEDULLIN; ANTIOXIDANT; BETA INTERFERON; BOSENTAN; CURCUMIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DECORIN; DEFERULOYLMETHANE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR; EPIGALLOCATECHIN GALLATE; FIBROBLAST GROWTH FACTOR; GALECTIN 3; GAMMA INTERFERON; GEMCITABINE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PLATELET DERIVED GROWTH FACTOR; PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR; SERPINE 2; SMAD7 PROTEIN; SMALL INTERFERING RNA; SOMATOMEDIN C; SONIC HEDGEHOG PROTEIN; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA1; TRAPIDIL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CARCINOGENESIS; CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; DRUG INHIBITION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; MOLECULARLY TARGETED THERAPY; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREATIC STELLATE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL DESTRUCTION; TUMOR VASCULARIZATION;

EID: 78651385353     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000320711     Document Type: Review

References (64)

1. Aho U, Zhao X, Löhr M, Andersson R: Mo-lecular mechanisms of pancreatic cancer and potential targets of treatment. Scand J Gas-troenterol 2007; 42: 279-296.
2. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ, American Cancer Society: Cancer statistics 2004. Ca J Clin 2004; 54:8-29. (Pubitemid 38443417)
3. Vonlaufen A, Phillips PA, Xu Z, Goldstein D, Pirola RC, Wilson JS, Apte MV: Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance. Cancer Res 2008; 68:7707-7710.
4. Hartel M, Di Mola FF, Gardini A, Zimmer-mann A, Di Sebastiano P, Guweidhi A, In-nocenti P, Giese T, Giese N, Büchler MW, Friess H: Desmoplastic reaction influences pancreatic cancer growth behavior. World J Surg 2004; 28:818-825. (Pubitemid 39315401)
5. Mahadevan D, Von Hoff DD: Tumor-stroma interactions in pancreatic ductal adenocar-cinoma. Mol Cancer Ther 2007; 6:1186-1197. (Pubitemid 46711982)
6. Korc M: Pancreatic cancer-associated stroma production. Am J Surg 2007; 194(suppl):S84-S86. (Pubitemid 47454597)
7. Bachem MG, Schunemann M, Ramadani M, Siech M, Beger H, Buck A, Zhou S, Schmid-Kotsas A, Adler G: Pancreatic carcinoma cells induce fibrosis by stimulating prolifera-tion and matrix synthesis of stellate cells. Gastroenterology 2005; 128:907-921. (Pubitemid 40523543)
8. Vonlaufen A, Joshi S, Qu C, Phillips PA, Xu Z, Parker NR, Toi CS, Pirola RC, Wilson JS, Goldstein D, Apte MV: Pancreatic stellate cells: partners in crime with pancreatic can-cer cells. Cancer Res 2008; 68:2085-2093. (Pubitemid 351521780)
9. Jiang HB, Xu M, Wang XP: Pancreatic stel-late cells promote proliferation and invasive-ness of human pancreatic cancer cells via galectin-3. World J Gastroenterol 2008; 14: 2023-2028. (Pubitemid 351795821)
10. Neesse A, Wagner M, Ellenrieder V Bachem M, Gress TM, Buchholz M: Pancreatic stel-late cells potentiate proinvasive effects of SERPINE2 expression in pancreatic cancer xenograft tumors. Pancreatology 2007; 7: 380-385. (Pubitemid 47482102)
11. Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, Pirola RC, Wilson JS: Periacinar stellate-shaped cells in rat pancreas: identification, isolation and culture. Gut 1998; 43:128-133. (Pubitemid 28335501)
12. Bachem MG, Schneider E, Gross H, Weiden-bach H, Schmid RM, Menke A, Siech M, Beger H, Grünert A, Adler G: Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroen-terology 1998; 115: 421-432.
13. Bachem MG, Zhou S, Buck K, Schneiderhan W, Siech M: Pancreatic stellate cells-role in pancreas cancer. Langenbecks Arch Surg 2008; 393: 891-900.
14. Omary MB, Lugea A, Lowe AW, Pandol SJ: The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 2007; 117: 50-59. (Pubitemid 46048449)
15. Masamune A, Shimosegawa T: Signal trans-duction in pancreatic stellate cells. J Gastro-enterol 2009; 44: 249-260.
16. Masamune A, Satoh M, Kikuta K, Suzuki N, Shimosegawa T: Activation of JAK-STAT pathway is required for platelet-derived growth factor-induced proliferation of pan-creatic stellate cells. World J Gastroenterol 2005; 11:3385-3391. (Pubitemid 40873243)
17. Jaster R, Sparmann G, Emmrich J, Liebe S: Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells. Gut 2002; 51: 579-584.
18. Masamune A, Kikuta K, Satoh M, Kume K, Shimosegawa T: Differential roles of signal-ing pathways for proliferation and migration of rat pancreatic stellate cells. Tohoku J Exp Med 2003; 199: 69-84. (Pubitemid 36519459)
19. Masamune A, Satoh M, Kikuta K, Sakai Y, Satoh A, Shimosegawa T: Inhibition of p38 mitogen-activated protein kinase blocks ac-tivation of rat pancreatic stellate cells. J Phar-macol Exp Ther 2003; 304: 8-14. (Pubitemid 36008906)
20. McCarroll JA, Phillips PA, Kumar RK, Park S, Pirola RC, Wilson JS, Apte MV: Pancre-atic stellate cell migration: role of the phos-phatidylinositol 3-kinase (PI3-kinase) path-way. Biochem Pharmacol 2004; 67:1215-1225. (Pubitemid 38296799)
21. Aoki H, Ohnishi H, Hama K, Shinozaki S, Kita H, Osawa H, Yamamoto H, Sato K, Tamada K, Sugano K: Cyclooxygenase-2 is required for activated pancreatic stellate cells to respond to proinflammatory cyto-kines. Am J Physiol Cell Physiol 2007; 292: 259-268.
22. Schneiderhan W, Diaz F, Fundel M, Zhou S, Siech M, Hasel C, Möller P, Gschwend JE, Seufferlein T, Gress T, Adler G, Bachem MG: Pancreatic stellate cells are an important source of MMP-2 in human pancreatic can-cer and accelerate tumor progression in a murine xenograft model and CAM assay. J Cell Sci 2007; 120:512-519. (Pubitemid 46332514)
23. Bailey JM, Swanson BJ, Hamada T, Eggers JP, Singh PK, Caffery T, Ouellette MM, Holling-sworth MA: Sonic hedgehog promotes des-moplasia in pancreatic cancer. Clin Cancer Res 2008; 14: 5995-6004.
24. Olive KP, Jacobetz MA, Davidson CJ, Gopi-nathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, Frese KK, Denicola G, Feig C, Combs C, Winter SP, Ireland-Zecchini H, Reichelt S, Howat WJ, Chang A, Dhara M, Wang L, Rückert F, Grützmann R, Pilarsky C, Izerad-jene K, Hingorani SR, Huang P, Davies SE, Plunkett W, Egorin M, Hruban RH, White-bread N, McGovern K, Adams J, Iacobuzio-Donahue C, Griffiths J, Tuveson DA: Inhibi-tion of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pan-creatic cancer. Science 2009; 324:1457-1461.
25. Feldmann G, Habbe N, Dhara S, Bisht S, Al-varez H, Fendrich V, Beaty R, Mullendore M, Karikari C, Bardeesy N, Ouellette MM, Yu W, Maitra A: Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer. Gut 2008; 57: 1420-1430.
26. Yoshida S, Ujiki M, Ding XZ, Pelham C, Ta-lamonti MS, Bell RH Jr, Denham W, Adrian TE: Pancreatic stellate cells (PSCs) express cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs. Mol Can-cer 2005; 4:27.
27. Fitzner B, Brock P, Holzhuter SA, Nizze H, Sparmann G, Emmrich J, Liebe S, Jaster R: Synergistic growth inhibitory effects of the dual endothelin-1 receptor antagonist bosentan on pancreatic stellate and cancer cells. Dig Dis Sci 2009; 54:309-320.
28. Buchholz M, Biebl A, Neesse A, Wagner M, Iwamura T, Leder G, Adler G, Gress TM: SERPINE2 (protease nexin I) promotes ex-tracellular matrix production and local inva-sion of pancreatic tumors in vivo. Cancer Res 2003; 63: 4945-4951. (Pubitemid 37022630)
29. Neesse A, Wagner M, Ellenrieder V, Bachem M, Gress TM, Buchholz M: Pancreatic stel-late cells potentiate proinvasive effects of SERPINE2 expression in pancreatic cancer xenograft tumors. Pancreatology 2007; 7: 380-385. (Pubitemid 47482102)
30. Hwang RF, Moore T, Arumugam T, Rama-chandran V, Amos KD, Rivera A, Ji B, Evans DB, Logsdon CD: Cancer-associated stromal fibroblasts promote pancreatic tumor pro-gression. Cancer Res 2008; 68:918-926. (Pubitemid 351206771)
31. Fujita H, Ohuchida K, Mizumoto K, Egami T, Miyoshi K, Moriyama T, Cui L, Yu J, Zhao M, Manabe T, Tanaka M: Tumor-stromal in-teractions with direct cell contacts enhance proliferation of human pancreatic carcino-ma cells. Cancer Sci 2009; 100: 2309-2317
32. Bomstein P: Matricellular proteins: an over-view. J Cell Commun Signal 2009; 3:163-165.
33. Grzesiak JJ, Bouvet M: The alpha2beta1 in-tegrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines. Br J Cancer 2006; 94: 1311-1319.
34. Yan Q, Sage EH: SPARC, a matricellular gly-coprotein with important biological func-tions. J Histochem Cytochem 1999; 47:1495-1506.
35. Tai IT, Tang MJ: SPARC in cancer biology: its role in cancer progression and potential for therapy. Drug Resist Updat 2008; 11: 231-246.
36. Guweidhi A, Kleeff J, Adwan H, Giese NA, Wente MN, Giese T, Büchler MW, Berger MR, Friess H: Osteonectin influences growth and invasion of pancreatic cancer cells. Ann Surg 2005; 242: 224-234. (Pubitemid 41033439)
37. Infante JR, Matsubayashi H, Sato N, Tonas-cia J, Klein AP, Riall TA, Yeo C, Iacobuzio-Donahue C, Goggins M: Peritumoral fibro-blast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma. J Clin Oncol 2007; 25:319-325. (Pubitemid 350003021)
38. Mantoni TS, Schendel RR, Rödel F, Niedobi-tek G, Al-Assar O, Masamune A, Brunner TB: Stromal SPARC expression and patient survival after chemoradiation for non-re-sectable pancreatic adenocarcinoma. Cancer Biol Ther 2008; 7: 1806-1815.
39. Chen G, Tian X, Liu Z, Schmidt B, Henne-Bruns D, Bachem M, Kornmann M: Inhibi-tion of endogenous SPARC enhances pan-creatic cancer cell growth: modulation by FGFR1-III isoform expression. Br J Cancer 2010; 102: 188-195.
40. Koninger J, Giese T, di Mola FF, Wente MN, Esposito I, Bachem MG, Giese NA, Büchler MW, Friess H: Pancreatic tumor cells influ-ence the composition of the extracellular matrix. Biochem Biophys Res Commun 2004; 322:943-949. (Pubitemid 39164444)
41. Esposito I, Penzel R, Chaib-Harrireche M, Barcena U, Bergmann F, Riedl S, Kayed H, Giese N, Kleeff J, Friess H, Schirmacher P: Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J Pathol 2006; 208: 673-685.
42. Kanno A, Satoh K, Masamune A, Hirota M, Kimura K, Umino J, Hamada S, Satoh A, Egawa S, Motoi F, Unno M, Shimosegawa T: Periostin, secreted from stromal cells, has bi-phasic effect on cell migration and correlates with the epithelial to mesenchymal transi-tion of human pancreatic cancer cells. Int J Cancer 2008; 122:2707-2718. (Pubitemid 351631372)
43. Phillips PA, McCarroll JA, Park S, Wu MJ, Pirola R, Korsten M, Wilson JS, Apte MV: Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extra-cellular matrix turnover. Gut 2003; 52:275-282. (Pubitemid 36115072)
44. Shek FW, Benyon RC, Walker FM, McCrud-den PR, Pender SL, Williams EJ, Johnson PA, Johnson CD, Bateman AC, Fine DR, Iredale JP: Expression of transforming growth fac-tor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turn-over in chronic pancreatitis. Am J Pathol 2002; 160:1787-1798. (Pubitemid 34525658)
45. Farrow B, Albo D, Berger DH: The role of the tumor microenvironment in the progression of pancreatic cancer. J Surg Res 2008; 149: 319-328.
46. Koong AC, Mehta VK, Le QT, Fisher GA, Terris DJ, Brown JM, Bastidas AJ, Vierra M: Pancreatic tumors show high levels of hyp-oxia. Int J Radiat Oncol Biol Phys 2000; 48: 919-922.
47. Erkan M, Reiser-Erkan C, Michalski CW, Deucker S, Sauliunaite D, Streit S, et al: Can-cer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma. Neoplasia 2009; 11:497-508.
48. Reiser-Erkan C, Erkan M, Pan Z, Bekasi S, Giese NA, Streit S, Michalski CW, Friess H, Kleeff J: Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma. Cancer Biol Ther 2008; 7:1352-1359.
49. Masamune A, Kikuta K, Watanabe T, Satoh K Hirota M, Shimosegawa T: Hypoxia stim-ulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic can-cer. Am J Physiol Gastrointest Liver Physiol 2008; 295:G709-G717.
50. Spector I, Honig H, Kawada N, Nagler A, Genin O, Pines M: Inhibition of pancreatic stellate cell activation by halofuginone pre-vents pancreatic xenograft tumor develop-ment. Pancreas 2010, E-pub ahead of print.
51. Jaster R, Sparmann G, Emmrich J, Liebe S: Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells. Gut 2002; 51: 579-584.
52. Masamune A, Suzuki N, Kikuta K, Satoh M, Satoh K, Shimosegawa T: Curcumin blocks activation of pancreatic stellate cells. J Cell Biochem 2006; 97:1080-1093.
53. Schwer CI, Guerrero AM, Humar M, Roess-lein M, Goebel U, Stoll P, Geiger KK, Pannen BH, Hoetzel A, Schmidt R: Heme oxygen-ase-1 inhibits the proliferation of pancreatic stellate cells by repression of the extracellu-lar signal-regulated kinase 1/2 pathway. J Pharmacol Exp Ther 2008; 327:863-871.
54. Masamune A, Kikuta K, Satoh M, Suzuki N, Shimosegawa T: Green tea polyphenol epi-gallocatechin-3-gallate blocks PDGF-in-duced proliferation and migration of rat pancreatic stellate cells. World J Gastroen-terol 2005; 11:3368-3374. (Pubitemid 40873241)
55. He J, Sun X, Qian KQ, Liu X, Wang Z, Chen Y: Protection of cerulein-induced pancreatic fibrosis by pancreas-specific expression of Smad7. Biochim Biophys Acta 2009; 1792: 56-60.
56. Truty MJ, Urrutia R: Basics of TGF-beta and pancreatic cancer. Pancreatology 2007; 7: 423-435.
57. Shen H, Zhang M, Minuk Gym Gong Y: Dif-ferent effects of rat interferon alpha, beta and gamma on rat hepatic stellate cell prolifera-tion and activation. BMC Cell Biol 2002; 3: 9.
58. Baumert JT, Sparmann G, Emmrich J, Liebe S, Jaster R: Inhibitory effects of interferons on pancreatic stellate cell activation. World J Gastroenterol 2006; 12:896-901.
59. Fitzner B, Brock P, Nechutova H, Glass A, Karopka T, Koczan D, Thiesen HJ, Spar-mann G, Emmrich J, Liebe S, Jaster R: In-hibitory effects of interferon-gamma on ac-tivation of rat pancreatic stellate cells are mediated by STAT1 and involve down-regu-lation of CTGF expression. Cell Signal 2007; 19: 782-790.
60. Koninger J, Giese NA, di Mola FF, Berberat P, Giese T, Esposito I, Bachem MG, Büchler MW, Friess H: Overexpressed decorin in pancreatic cancer: potential tumor growth inhibition and attenuation of chemothera-peutic action. Clin Cancer Res 2004; 10: 4776-4783. (Pubitemid 38955530)
61. Farrow B, Berger DH, Rowley D: Tumor-de-rived pancreatic stellate cells promote pan-creatic cancer cell invasion through release of thrombospondin-2. J Surg Res 2009; 156: 155-160.
62. Ramachandran V, Arumugam T, Hwang RF, Greenson JK, Simeone DM, Logsdon CD: Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the ad-renomedullin receptor, ADMR. Cancer Res 2007; 67:2666-2675. (Pubitemid 46548954)
63. Ramachandran V, Arumugam T, Langley R, Hwang RF, Vivas-Mejia P, Sood AK, Lopez-Berestein G, Logsdon CD: The ADMR recep-tor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment. PLoS One 2009; 4:e7502.
64. Shimizu M: Mechanisms of pancreatic fibro-sis and applications to the treatment of chronic pancreatitis. J Gastroenterol 2008; 43:823-832.